PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
PROCEPt BioRobotics公佈強勁的第三季度收益，加入Monte Rosa Therapeutics、eyepoint pharmaceuticals和其他大型股票週一走高
Here are some other big stocks recording gains in today's session.U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Monday.
美國股市上漲，道瓊斯指數週一上漲約200點。
Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) rose sharply during Monday's session after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance.
PROCEPt BioRobotics公司（納斯達克：PRCT）股票在週一的交易中大幅上漲，該公司公佈了好於預期的第三季度財務業績，並提高了其FY24營業收入指引。
PROCEPT BioRobotics shares jumped 25% to $85.87 on Monday.
PROCEPt BioRobotics股票週一上漲25%，報85.87美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易中漲幅較大的其他大股票。
- Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) shares jumped 60.5% to $7.85 after the company announced a global license agreement with Novartis to advance VAV1 MGDs. The company will receive a $150 million upfront payment and is eligible for additional milestone payments.
- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) gained 33.6% to $12.69 after the company showed early trial data for DURAVYU for diabetic macular edema and announced improving vision and anatomy.
- Revance Therapeutics, Inc. (NASDAQ:RVNC) shares gained 25.5% to $5.89 after the company announced it entered into the sixth amendment to its exclusive distribution agreement with Teoxane.
- ImmunityBio, Inc. (NASDAQ:IBRX) gained 19.5% to $6.36.
- Trump Media & Technology Group Corp. (NASDAQ:DJT) rose 15.3% to $44.91. The stock may be moving amid possible volatility as traders evaluate his chance of winning the 2024 presidential election.
- Prothena Corporation plc (NASDAQ:PRTA) surged 15.3% to $17.66.
- Serve Robotics Inc. (NASDAQ:SERV) gained 13.8% to $11.09. Ladenburg Thalmann analyst Glenn Mattson initiated coverage on Serve Robotics with a Buy rating and announced a price target of $16.
- Vera Therapeutics, Inc. (NASDAQ:VERA) rose 12.1% to $46.05 after the company reported 96-week eGFR stabilization on Saturday for its Phase 2b study of IgAN patients with Atacicept.
- MINISO Group Holding Limited (NASDAQ:MNSO) gained 10.3% to $19.21.
- TeraWulf Inc. (NASDAQ:WULF) rose 10.2% to $7.03.
- WeRide Inc. (NASDAQ:WRD) gained 9% to $18.03.
- Newell Brands Inc. (NASDAQ:NWL) rose 8.3% to $9.45. Canaccord Genuity analyst Brian McNamara maintained Newell Brands with a Buy and raised the price target from $12 to $13.
- MicroStrategy Incorporated (NASDAQ:MSTR) gained 7% to $251.00 amid a rise in Bitcoin.
- MARA Holdings, Inc. (NASDAQ:MARA) rose 6.3% to $18.14 amid a rise in Bitcoin.
- Monte Rosa Therapeutics公司（納斯達克：GLUE）宣佈與諾華達成全球授權協議，推進VAV1 MGDs，股價上漲60.5%，至7.85美元。該公司將收到一筆15000萬美元的預付款，並有資格獲得額外的里程碑付款。
- EyePoint Pharmaceuticals公司（納斯達克：EYPT）股價上漲33.6%，至12.69美元，該公司展示了DURAVYU用於糖尿病性黃斑水腫的早期試驗數據，並宣佈視力和解剖結構有所改喡。
- Revance Therapeutics公司（納斯達克：RVNC）股價上漲25.5%，至5.89美元，該公司宣佈與Teoxane簽署獨家分銷協議第六修正案。
- ImmunityBio公司（納斯達克：IBRX）股價上漲19.5%，至6.36美元。
- 特朗普媒體與技術集團股份公司（納斯達克: 道瓊斯）上漲了15.3%，至44.91美元。隨着交易員評估他在2024年總統大選中獲勝的機會，該股票可能出現波動。
- Prothena公司股份有限公司（納斯達克:PRTA）大漲15.3%，至17.66美元。
- Serve Robotics公司（納斯達克: SERV）漲了13.8%，至11.09美元。 Ladenburg Thalmann的分析師格倫·馬特森（Glenn Mattson）開始對Serve Robotics進行買入評級，並宣佈將價格目標定爲16美元。
- Vera Therapeutics公司（納斯達克:VERA）上漲了12.1%，至46.05美元，此前該公司報告了週六在其對Atacicept型IgAN患者進行的20億階段研究中96周eGFR的穩定。
- 名創優品控股有限公司（納斯達克:MNSO）上漲了10.3%，至19.21美元。
- TeraWulf公司（納斯達克:WULF）上漲了10.2%，至7.03美元。
- WeRide公司（納斯達克:WRD）上漲了9%，至18.03美元。
- 紐威品牌公司（納斯達克:NWL）上漲了8.3%，至9.45美元。Canaccord Genuity的分析師布賴恩·麥克納馬拉（Brian McNamara）維持對紐威品牌的買入評級，並將價格目標從12美元提高到13美元。
- microstrategy公司（納斯達克股票代碼：MSTR）的股價上漲7%，至251.00美元，受比特幣上漲影響。
- MARA Holdings, Inc.（納斯達克股票代碼：MARA）的股價上漲6.3%，至18.14美元，受比特幣上漲影響。
Now Read This:
現在閱讀這個：
- Top 3 Real Estate Stocks That May Surge In Q4
- 可能在第四季度大漲的前三家房地產業股票
資訊熱榜
更新時間